How do you manage HR+HER2 negative ILC metastatic recurrence in a post-menopausal woman with extensive GI involvement complicated by a small bowel obstruction?   
Patient was on tamoxifen when progression occurred; unable to tolerate adjuvant AI.

Medical Oncologist
Medical Oncologist at Moffitt Cancer Center and Rsrch Inst
I agree with Dr. @Jeffrey B. VanDeusen. In this ca...
Sign in or Register to read more